Daily Sepsis Research Analysis
Three studies advance sepsis science from precision hemodynamics to prevention and neuroinflammation. A large ICU cohort reveals phenotype-specific heterogeneity in vasopressor dose–time effects on mortality, a Mendelian randomization study supports causal links between education and reduced sepsis risk via modifiable factors, and preclinical work uncovers a lactate-driven pathway that mobilizes skull bone marrow neutrophils to meninges in sepsis-associated encephalopathy.
Summary
Three studies advance sepsis science from precision hemodynamics to prevention and neuroinflammation. A large ICU cohort reveals phenotype-specific heterogeneity in vasopressor dose–time effects on mortality, a Mendelian randomization study supports causal links between education and reduced sepsis risk via modifiable factors, and preclinical work uncovers a lactate-driven pathway that mobilizes skull bone marrow neutrophils to meninges in sepsis-associated encephalopathy.
Research Themes
- Precision hemodynamics and heterogeneous treatment effects in sepsis
- Socioeconomic determinants and prevention pathways of sepsis
- Neuroimmune mechanisms in sepsis-associated encephalopathy
Selected Articles
1. Analysis of the heterogeneous treatment effect of vasoactive drug dosage and time on hospital mortality across different sepsis phenotypes: a retrospective cohort study.
In >54,000 ICU sepsis cases, four data-driven phenotypes showed distinct mortality responses to vasoactive exposure. Each 0.05 μg/kg/min increase in norepinephrine-equivalent dose and longer exposure were associated with higher mortality, with strong phenotype–dose–time interactions and a U-shaped risk curve in the most severe phenotype (D).
Impact: This is one of the most comprehensive analyses of vasopressor exposure-time effects across sepsis phenotypes, advancing precision hemodynamics by quantifying heterogeneous treatment effects.
Clinical Implications: Vasopressor dosing and duration may need phenotype-specific targets. Until prospective validation, clinicians should be cautious with dose escalation and prolonged exposure, recognizing that risk slopes vary by phenotype and that some subgroups may have optimal exposure windows.
Key Findings
- Four sepsis phenotypes (A–D) were derived; D was most severe, C next, A/B milder.
- Per 0.05 μg/kg/min increase in norepinephrine-equivalent dose, hospital mortality increased (OR 1.328, 95% CI 1.314–1.342).
- Longer vasoactive use further increased mortality (OR 1.006 per hour, 95% CI 1.005–1.007).
- Phenotype-specific interactions were significant (Pinteraction < 0.001).
- RCS: A showed higher mortality at 0.1–0.5 μg/kg/min; B had steepest risk rise with dose/time; C peaked >0.5 μg/kg/min; D showed a U-shaped curve with lowest mortality around 0.03–0.05 μg/kg/min.
Methodological Strengths
- Large, multi-database ICU cohort with hourly vasopressor exposure captured up to 72 hours
- Advanced modeling of phenotype–dose–time interactions with DAG/ML-informed covariate adjustment and RCS
- Bonferroni-adjusted interaction testing to control type I error
Limitations
- Retrospective observational design with potential residual confounding despite adjustments
- Phenotype derivation and norepinephrine-equivalence assumptions may limit generalizability
- Only 8,803 patients had detailed vasoactive exposure for HTE analysis
Future Directions: Prospective trials to test phenotype-specific vasopressor strategies; develop real-time clinical decision support integrating phenotype and dose–time risk curves; validate in external, contemporary cohorts.
BACKGROUND: The heterogeneity of sepsis poses challenges for the individualized treatment of vasoactive drugs. METHODS: This study used data from ICUs in MIMIC-IV (2008-2019) and eICU (2014-2015) databases, identified sepsis by sepsis-3 criteria, and stratified sepsis into phenotypes by consensus K-means. The norepinephrine equivalence (NEE) formula balance treatment of different vasoactive drugs, with NEE captured hourly for up to 72 h to record both time of use and dosage. The logistic regression model, including phenotype-dosage-time interactions, examined heterogeneous treatment effects on hospital mortality. To address confounding, three models were fitted: Model 1 unadjusted, Model 2 adjusted for age and sex, and Model 3 additionally included 7 clinical variables identified via machine learning and directed acyclic graph. Nonlinear dosage was further analyzed based on restricted cubic splines. P values and P for interaction were Bonferroni-adjusted. RESULTS: A total of 54,673 sepsis patients were included for phenotype identification, and 8,803 patients were further analyzed to evaluate heterogeneous treatment effect of vasoactive drugs. Four sepsis phenotypes were identified: A, B, C and D. Phenotype D was the most severe subgroup, followed by phenotype C, while phenotypes A and B were mild subgroups. In Model 3, each 0.05 μg/kg/min increase in NEE dosage was linked to higher hospital mortality (OR 1.328, 95% CI 1.314-1.342; p < 0.001). Longer NEE time of use also significantly increased mortality risk (OR 1.006, 95% CI 1.005-1.007; p < 0.001). In addition, these associations varied significantly by phenotype (P for interaction < 0.001). In RCS model, phenotype A consistently showed higher mortality than the other phenotypes at NEE dosages of 0.1-0.5 µg/kg/min, with this gap increasing over time, showing a clear dosage-time dependence. Phenotype B displayed lower overall mortality but the steepest relative risk of hospital mortality increased as dosage and time (OR of dosage: 1.309; OR of time: 1.005) in Model 3. Phenotype C reached the highest mortality risk when dosages exceeded 0.5 µg/kg/min, which was dosage dependence. Finally, phenotype D followed a U-shaped curve in RCS model, and minimum mortality was around 20% at 0.03-0.05 µg/kg/min. CONCLUSIONS: Sepsis phenotypes differ significantly in their treatment effects of vasoactive drug dosage and time of use, indicating the need for phenotype-specific treatment strategies to improve outcomes.
2. Lactate exacerbates neuroinflammation in sepsis-associated encephalopathy via promoting neutrophil migration from skull bone marrow to the meninge.
In an LPS-induced mouse model of SAE, skull bone marrow lactate rose, coinciding with depletion of marrow neutrophils and increased meningeal neutrophil infiltration. Exogenous lactate reproduced these effects, whereas LDH inhibition (FX-11) attenuated lactate production, implicating lactate in driving skull marrow-to-meninges neutrophil trafficking and neuroinflammation.
Impact: This study reveals a previously underappreciated lactate-driven route linking skull marrow neutrophil egress to meningeal inflammation in SAE, opening therapeutic avenues targeting metabolism or neutrophil trafficking.
Clinical Implications: Although preclinical, findings support exploring LDH inhibition, lactate modulation, or blockade of marrow–meninges trafficking as strategies to mitigate SAE-related neuroinflammation.
Key Findings
- SAE mice exhibited significantly elevated lactate in skull bone marrow with concomitant depletion of marrow neutrophils.
- Neutrophil extravasation into the meninges increased in SAE; exogenous lactate reproduced these effects in non-septic mice.
- Pharmacologic inhibition of lactate production with FX-11 attenuated the lactate surge, implicating lactate in driving marrow-to-meninges neutrophil trafficking.
Methodological Strengths
- In vivo SAE model with both pharmacologic inhibition (FX-11) and exogenous metabolite challenge
- Multiparametric cellular readouts using immunofluorescence and flow cytometry
- Anatomically specific focus on skull bone marrow–meninges axis
Limitations
- Mouse LPS model may not fully recapitulate human SAE pathophysiology
- Mechanistic details are truncated in the abstract and require full-text clarification
- Functional/behavioral neurological outcomes were not described in the abstract
Future Directions: Validate marrow–meninges neutrophil trafficking in human SAE; assess cognitive outcomes; test metabolic or trafficking inhibitors in translational models.
Sepsis-associated encephalopathy (SAE) is one of the most common and severe complications of sepsis. Although lactate and neutrophils play pivotal roles in SAE, the mechanisms linking lactate, neutrophils, and neuroinflammation in SAE remain largely unclear. In this study, SAE model was induced in C57BL/6 J mice via intraperitoneal lipopolysaccharide (LPS) injection, with lactate production inhibited by administering the lactate dehydrogenase inhibitor FX-11. Neutrophils were visualized by immunofluorescence, and immune cell subsets were quantified via flow cytometry. Our findings revealed that lactate levels in the skull bone marrow (SBM) were significantly elevated in SAE mice, accompanied by decreased SBM neutrophils and increased neutrophil extravasation into the meninges. These effects were reproduced in exogenous lactate-administered normal mice. Further studies identified that a CD31
3. Examining socioeconomic differences in sepsis risk and mediation by modifiable factors: a Mendelian randomization study.
Genetically proxied educational attainment was causally associated with lower sepsis risk (OR 0.72 per SD increase), robust to multiple sensitivity analyses including within-sibship MR. Modifiable factors (e.g., smoking, alcohol, BMI, HDL, SBP, type 2 diabetes) mediated 56% of the protective effect.
Impact: By leveraging MR with a within-family instrument, this study strengthens causal inference for socioeconomic determinants of sepsis and quantifies actionable mediation pathways.
Clinical Implications: Public health and preventive strategies that improve educational opportunities and target modifiable risk factors could meaningfully reduce sepsis incidence and narrow socioeconomic disparities.
Key Findings
- Each 1 SD (3.4 years) increase in genetically predicted education reduced sepsis risk (OR 0.72, 95% CI 0.66–0.78).
- Findings were consistent in sensitivity analyses including within-sibship MR (OR 0.88, 95% CI 0.64–1.18), weighted median (OR 0.70), weighted mode (OR 0.70), and MR Egger (OR 0.65).
- Multivariable MR mediation indicated 56% of the protective effect was explained by modifiable/preventable factors (e.g., smoking, alcohol, BMI, HDL, SBP, type 2 diabetes).
Methodological Strengths
- Two-sample MR using large GWAS summary data with multiple sensitivity estimators
- Within-sibship genetic instrument reduces confounding by population stratification and dynastic effects
- Multivariable MR quantifies mediation by modifiable risk factors
Limitations
- MR assumptions (relevance, independence, exclusion restriction) may be violated by horizontal pleiotropy despite sensitivity analyses
- Summary-level data preclude individual-level confounder assessment and subgroup analyses
- Generalizability depends on ancestry composition of contributing GWAS
Future Directions: Conduct ancestry-diverse, individual-level MR and quasi-experimental studies; test targeted interventions on identified mediators to reduce sepsis incidence.
BACKGROUND: Educational attainment is inversely related to sepsis risk, but the causal nature is still unclear. We therefore conducted the first Mendelian randomization (MR) study of genetically predicted educational attainment on sepsis that also uses a within-family genetic instrument for education. To further explore possible mechanistic pathways that can inform strategies to reduce sepsis risk, we examined the mediating effects of factors that are modifiable or can be prevented. METHODS: The association between genetically predicted educational attainment and sepsis was estimated using summary-level data from recent genome-wide association studies. Possible bias due to population stratification, dynastic effects, and assortative mating in the genetic instrument for education was evaluated using summary-level data from a within-sibship genome-wide association study. We used inverse variance weighted MR analysis to estimate the effect of one standard deviation increase in years of education on sepsis risk. The robustness of the findings was assessed in sensitivity analyses, applying weighted median, weighted mode, and MR Egger regression. Finally, we applied multivariable MR analyses to estimate the mediating effects of smoking initiation, alcohol consumption, body mass index, high-density lipoprotein (HDL)-cholesterol, systolic blood pressure and type 2 diabetes. RESULTS: For each standard deviation increase in genetically predicted educational attainment (3.4 years), the odds ratio (OR) for sepsis was 0.72 (95% confidence interval (CI) 0.66 to 0.78). The results of the analysis using the within-sibship genetic instrument and other sensitivity analyses were in line with this finding: within-sibship OR 0.88 (95% CI 0.64 to 1.18), weighted median OR 0.70 (95% CI 0.62 to 0.80), weighted mode OR 0.70 (95% CI 0.43 to 1.13), and MR Egger OR 0.65 (95% CI 0.50 to 0.85). The mediation analysis showed that 56% of the effect of educational attainment on sepsis risk can be explained by modifiable or preventable factors. CONCLUSIONS: Higher educational attainment is strongly associated with a reduced risk of sepsis, pointing to important socioeconomic differences in this disease. The results also suggest that interventions targeting modifiable or preventable factors could contribute to reducing the socioeconomic differences in sepsis risk.